221 related articles for article (PubMed ID: 20973823)
1. Recent epidemiology of Clostridium difficile infection during hematopoietic stem cell transplantation.
Chopra T; Chandrasekar P; Salimnia H; Heilbrun LK; Smith D; Alangaden GJ
Clin Transplant; 2011; 25(1):E82-7. PubMed ID: 20973823
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.
Huang AM; Marini BL; Frame D; Aronoff DM; Nagel JL
Transpl Infect Dis; 2014 Oct; 16(5):744-50. PubMed ID: 25040545
[TBL] [Abstract][Full Text] [Related]
3. Clostridium difficile infection after allogeneic hematopoietic stem cell transplant: strain diversity and outcomes associated with NAP1/027.
Kamboj M; Xiao K; Kaltsas A; Huang YT; Sun J; Chung D; Wu S; Sheahan A; Sepkowitz K; Jakubowski AA; Papanicolaou G
Biol Blood Marrow Transplant; 2014 Oct; 20(10):1626-33. PubMed ID: 24973628
[TBL] [Abstract][Full Text] [Related]
4. Oral Vancomycin Prophylaxis as Secondary Prevention Against Clostridioides difficile Infection in the Hematopoietic Stem Cell Transplantation and Hematologic Malignancy Population.
Morrisette T; Van Matre AG; Miller MA; Mueller SW; Bajrovic V; Abidi MZ; Benamu E; Kaiser JN; Barber GR; Chase S; Tobin J; Fish DN; Gutman JA
Biol Blood Marrow Transplant; 2019 Oct; 25(10):2091-2097. PubMed ID: 31255741
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology and clinical characteristics of Clostridium difficile infection in a Korean tertiary hospital.
Kim J; Pai H; Seo MR; Kang JO
J Korean Med Sci; 2011 Oct; 26(10):1258-64. PubMed ID: 22022175
[TBL] [Abstract][Full Text] [Related]
6. Clostridium difficile infection after allogeneic hematopoietic stem cell transplantation: incidence, risk factors, and outcome.
Willems L; Porcher R; Lafaurie M; Casin I; Robin M; Xhaard A; Andreoli AL; Rodriguez-Otero P; Dhedin N; Socié G; Ribaud P; Peffault de Latour R
Biol Blood Marrow Transplant; 2012 Aug; 18(8):1295-301. PubMed ID: 22387347
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology and outcomes of Clostridium difficile infections in hematopoietic stem cell transplant recipients.
Alonso CD; Treadway SB; Hanna DB; Huff CA; Neofytos D; Carroll KC; Marr KA
Clin Infect Dis; 2012 Apr; 54(8):1053-63. PubMed ID: 22412059
[TBL] [Abstract][Full Text] [Related]
8. Clostridioides difficile infection in solid organ and hematopoietic stem cell transplant recipients: A prospective multinational study.
Blumberg EA; Collins G; Young JH; Nguyen MH; Michonneau D; Temesgen Z; Origȕen J; Barcan L; Obeid KM; Belloso WH; Gras J; Corbelli GM; Neaton JD; Lundgren J; Snydman DR; Molina JM;
Transpl Infect Dis; 2022 Feb; 24(1):e13770. PubMed ID: 34821423
[TBL] [Abstract][Full Text] [Related]
9. Clostridium Difficile Colonization in Hematopoietic Stem Cell Transplant Recipients: A Prospective Study of the Epidemiology and Outcomes Involving Toxigenic and Nontoxigenic Strains.
Jain T; Croswell C; Urday-Cornejo V; Awali R; Cutright J; Salimnia H; Reddy Banavasi HV; Liubakka A; Lephart P; Chopra T; Revankar SG; Chandrasekar P; Alangaden G
Biol Blood Marrow Transplant; 2016 Jan; 22(1):157-63. PubMed ID: 26211988
[TBL] [Abstract][Full Text] [Related]
10. An Algorithm Addressing the Problem of Overdiagnosis of Clostridioides difficile Infections in Hematopoietic Stem Cell Transplantation Recipients: Effects on C. difficile Infection Rates and Patient Outcomes.
Ford CD; Hoda D; Lopansri BK; Parra M; Sharma P; Asch J
Transplant Cell Ther; 2023 Jul; 29(7):471.e1-471.e7. PubMed ID: 37086852
[TBL] [Abstract][Full Text] [Related]
11. Clostridium difficile infection after adult autologous stem cell transplantation: a multicenter study of epidemiology and risk factors.
Alonso CD; Dufresne SF; Hanna DB; Labbé AC; Treadway SB; Neofytos D; Bélanger S; Huff CA; Laverdière M; Marr KA
Biol Blood Marrow Transplant; 2013 Oct; 19(10):1502-8. PubMed ID: 23916741
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Risk Factors for Clostridium difficile Infection in Hematopoietic Stem Cell Transplant Recipients.
Scardina TL; Kang Martinez E; Balasubramanian N; Fox-Geiman M; Smith SE; Parada JP
Pharmacotherapy; 2017 Apr; 37(4):420-428. PubMed ID: 28226419
[TBL] [Abstract][Full Text] [Related]
13. Clostridioides difficile Infection and Risk of Acute Graft-versus-Host Disease among Allogeneic Hematopoietic Stem Cell Transplantation Recipients.
Jabr R; El Atrouni W; Shune L; Telfah M; Gao G; He J; Abhyankar S; McGuirk J; Clough L
Transplant Cell Ther; 2021 Feb; 27(2):176.e1-176.e8. PubMed ID: 33830032
[TBL] [Abstract][Full Text] [Related]
14. Impact of Clostridioides difficile infection on the outcome of patients receiving a hematopoietic stem cell transplantation.
Weber S; Scheich S; Magh A; Wolf S; Enßle JC; Brunnberg U; Reinheimer C; Wichelhaus TA; Kempf VAJ; Kessel J; Vehreschild MJGT; Serve H; Bug G; Steffen B; Hogardt M
Int J Infect Dis; 2020 Oct; 99():428-436. PubMed ID: 32798661
[TBL] [Abstract][Full Text] [Related]
15. Early Clostridium difficile infection during allogeneic hematopoietic stem cell transplantation.
Kinnebrew MA; Lee YJ; Jenq RR; Lipuma L; Littmann ER; Gobourne A; No D; van den Brink M; Pamer EG; Taur Y
PLoS One; 2014; 9(3):e90158. PubMed ID: 24662889
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of
Luo Y; Zhang S; Shang H; Cui W; Wang Q; Zhu B
Front Cell Infect Microbiol; 2022; 12():801475. PubMed ID: 35265530
[TBL] [Abstract][Full Text] [Related]
17. A retrospective review of metronidazole and vancomycin in the management of Clostridium difficile infection in patients with hematologic malignancies.
Parmar SR; Bhatt V; Yang J; Zhang Q; Schuster M
J Oncol Pharm Pract; 2014 Jun; 20(3):172-82. PubMed ID: 23804627
[TBL] [Abstract][Full Text] [Related]
18. Clostridioides difficile infection in paediatric patients with cancer and haematopoietic stem cell transplant recipients.
Haeusler GM; Lehrnbecher T; Agyeman PKA; Loves R; Castagnola E; Groll AH; van de Wetering M; Aftandilian CC; Phillips B; Chirra KM; Schneider C; Dupuis LL; Sung L
Eur J Cancer; 2022 Aug; 171():1-9. PubMed ID: 35696884
[TBL] [Abstract][Full Text] [Related]
19. Epidemiologic and Clinical Characteristics of Clostridioides difficile Infections in Hospitalized and Outpatient Pediatric Oncology and Hematopoietic Stem Cell Transplant Patients.
Barbar R; Hayden R; Sun Y; Tang L; Hakim H
Pediatr Infect Dis J; 2021 Jul; 40(7):655-662. PubMed ID: 34097657
[TBL] [Abstract][Full Text] [Related]
20. Clostridium difficile: deleterious impact on hematopoietic stem cell transplantation.
Callejas-Díaz A; Gea-Banacloche JC
Curr Hematol Malig Rep; 2014 Mar; 9(1):85-90. PubMed ID: 24390550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]